(NU/1433-16) NunaBio: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation

NunaBio Ltd has developed an enhanced DNA sensing platform technology and associated IP that will find application in many market sectors that require increased confidence in the sensitive detection of target DNA sequences. Consumers of diagnostic devices require their device to be sensitive and accurate. While 100% accuracy is possible, existing approaches require highly trained staff, expensive labs and significant lead time to results. These drawbacks are key drivers for the development of point-of-use devices which aim to support better decision making, reduce cost (social and economic) and time to action. The utility of such devices and therefore consumer confidence in the results they produce is highly dependent on their accuracy. Exemplified by the current COVID-19 pandemic, there is an urgent unmet need for advanced confidence. We are looking for an executive and the initial brief of the executive will be to: (1) Produce a viable 5 year business plan; (2) Obtain university approval for the venture; (3) a. Act for the company in the spin-out legal process and address all company formation matters; b. Obtain founder academics' and Newcastle University (including the Head of Company Creation) approval for appointment as CEO. c. Provide to the appropriate university all matters necessary for ERDF reporting requirements; (4) Secure (venture capital and other) funding